You searched for prescription-drugs | Page 2 of 180

More Than 4 Million Medicare Beneficiaries Will Have Their Medicare Advantage or Stand-Alone Prescription Drug Plan Terminated at the End of 2026

Oct 27, 2026

Issue Brief

Data from the Centers for Medicare & Medicaid Services (CMS) shows that 4.3 million Medicare beneficiaries, including 3.1 million Medicare Advantage drug plan enrollees and 1.2 million PDP enrollees, will have their plan terminated at the end of 2026. An additional 1.4 million Medicare Advantage enrollees are in a plan that is consolidating with another plan offered by the same insurer.

Developments in Prescription Drug Pricing under the Second Trump Administration

Event Date: Nov 20, 2025

Event

Three experts joined Larry Levitt, executive vice president for health policy at KFF, for a discussion about the latest developments in prescription drug pricing and what they mean for drug manufacturers, patients and public and private health insurance programs.

KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use

Nov 14, 2025

Poll Finding

About one in eight adults say that they are currently taking a GLP-1 drug either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern. Few adults think it is likely their prescription costs will go down as a result of recently announced Trump administration policies.

The Uncertain Future of Medicare’s Stand-Alone Prescription Drug Plan Market and Why It Matters

Jul 16, 2025

Issue Brief

This brief focuses on the stand-alone Medicare Part D prescription drug plan marketplace and its somewhat uncertain future, in light of recent trends in plan availability and the potential for another year of premium increases in 2026, in part depending on what the Trump administration decides to do with the temporary Part D premium stabilization demonstration. The brief explains why the stability of the PDP market matters, both for people in traditional Medicare who want…

Part D Retail Prescription Drugs

May 4, 2026

State Health Facts Indicator

Number of Medicare Stand-alone Prescription Drug Plans (PDPs)

Apr 10, 2026

State Health Facts Indicator

Part D Mail Order Prescription Drugs

May 4, 2026

State Health Facts Indicator

Quick fact graphic from KFF that states “As of early March, a majority of the public (59%) is worried about affording prescription drugs for themselves and their families, the largest share since KFF first polled this question in 2018.” In the top right corner, there’s a donut chart depicting 59%. Source is KFF polling (Feb. 24-March 2, 2026).

As TrumpRx Expands to Include Generic Drugs, KFF Polling Shows Nearly 6 in 10 Adults Are Worried About Prescription Drug Costs

May 18, 2026

Quick Insights

As of early March, a majority of the public (59%) is worried about affording prescription drugs for themselves and their families, the largest share since KFF first polled this question in 2018.

Poll: Public Worries About Prescription Drug Costs Reach New High; Most Across Political Parties Want Government to Do More to Regulate Prices

Mar 13, 2026

News Release

As the Trump administration promotes its new TrumpRx website and other efforts to lower prescription drug prices, a growing majority of the public worries about being able to afford prescription drugs, and large majorities across parties want the government to do more to regulate prices, a new KFF Health Tracking Poll finds.

FAQs on Prescription Drug Importation

Mar 11, 2024

Issue Brief

These FAQs address questions related to prescription drug importation, including the current status of importation proposals, details of Florida’s importation program recently authorized by the FDA, and concerns and challenges with this approach.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter